Pardes Biosciences, Inc.

NasdaqGM:PRDS Stock Report

Market Cap: US$131.2m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Pardes Biosciences Balance Sheet Health

Financial Health criteria checks 6/6

Pardes Biosciences has a total shareholder equity of $155.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $157.3M and $1.9M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$153.20m
EquityUS$155.39m
Total liabilitiesUS$1.93m
Total assetsUS$157.31m

Recent financial health updates

Recent updates

We're Keeping An Eye On Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Rate

Jul 18
We're Keeping An Eye On Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Rate

Here's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation

Jan 20
Here's Why We're Watching Pardes Biosciences' (NASDAQ:PRDS) Cash Burn Situation

We Think Pardes Biosciences (NASDAQ:PRDS) Needs To Drive Business Growth Carefully

Oct 01
We Think Pardes Biosciences (NASDAQ:PRDS) Needs To Drive Business Growth Carefully

Pardes begins phase 2 trial of oral drug PBI-0451 for COVID-19

Sep 13

Pardes Biosciences GAAP EPS of -$0.48

Aug 15

Pardes Biosciences (NASDAQ:PRDS) Is In A Good Position To Deliver On Growth Plans

Jun 14
Pardes Biosciences (NASDAQ:PRDS) Is In A Good Position To Deliver On Growth Plans

Pardes Biosciences: Advancing A Viral Protease Inhibitor Platform

Jan 21

Financial Position Analysis

Short Term Liabilities: PRDS's short term assets ($157.3M) exceed its short term liabilities ($1.9M).

Long Term Liabilities: PRDS has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: PRDS is debt free.

Reducing Debt: PRDS has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: PRDS has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: PRDS has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 75.6% each year.


Discover healthy companies